USPTO serial 87953241
BUDS & ROSES
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DANTZLER, LAUREN ALEXANDRIA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BUDS & ROSES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Retail store services featuring a wide variety of consumer goods of others, not including marijuana and marijuana-related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; Retail store services featuring smoking products, namely, cigarettes, pre-rolled cigarettes, vape pens, vaporizer pens, oral vaporizers for smoking purposes, cartridges for oral vaporizers, electronic cigarettes, cartridges for electronic cigarettes, cartridges sold filled with chemical flavorings in liquid form for electronic cigarettes, cartridges sold filled with vegetable glycerin for electronic cigarettes, herbs for smoking, concentrates for smoking, batteries for electronic cigarettes, and batteries for oral vaporizers for smoking purposes, rolling papers for smokers, lighters for smokers, pipes for smokers, cigarettes sold empty, vape pens sold empty, vaporizer pens sold empty, oral vaporizers for smoking purposes sold empty, electronic cigarettes sold empty, all of the foregoing not including marijuana and marijuana related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; Retail store services featuring medicinal herbs and herbs for medical purposes, all of the foregoing not including marijuana and marijuana related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; Retail store services featuring clothing and apparel, all of the foregoing not including marijuana and marijuana related substances; Retail convenience stores, not including marijuana and marijuana-related substances, all the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; Retail variety stores, not including marijuana and marijuana-related substances, all the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; On-line retail store services featuring smoking products, namely, cigarettes, pre-rolled cigarettes, vape pens, vaporizer pens, oral vaporizers for smoking purposes, cartridges for oral vaporizers, electronic cigarettes, cartridges for electronic cigarettes, cartridges sold filled with chemical flavorings in liquid form for electronic cigarettes, cartridges sold filled with vegetable glycerin for electronic cigarettes, herbs for smoking, concentrates for smoking, batteries for electronic cigarettes, and batteries for oral vaporizers for smoking purposes, rolling papers for smokers, lighters for smokers, pipes for smokers, cigarettes sold empty, vape pens sold empty, vaporizer pens sold empty, oral vaporizers for smoking purposes sold empty, electronic cigarettes sold empty, all of the foregoing not including marijuana and marijuana-related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; On-line retail store services featuring medicinal herbs and herbs for medical purposes, all of the foregoing not including marijuana and marijuana-related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis; On-line retail store services featuring clothing and apparel, all of the foregoing not including marijuana and marijuana related substances; On-line retail store services featuring a wide variety of consumer goods of others, not including marijuana and marijuana-related substances, all of the foregoing services featuring products containing cannabis or cannabis derivatives solely with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis, all of the foregoing services not featuring any orally-ingestible products containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any beverages containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any dietary or nutritional supplements containing more than trace amounts of cannabidiol, all of the foregoing services not featuring any pharmaceuticals containing cannabidiol, all of the foregoing services not featuring any medications containing cannabidiol, and all of the foregoing services not featuring any topical analgesic creams containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any ointments containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any balms containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any lotions containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring any soaks containing cannabidiol as an active pharmaceutical ingredient, and all of the foregoing services not featuring products primarily intended or designed for use in connection with cannabis or cannabis derivatives with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 2, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 8, 2024 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Nov 8, 2024 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Oct 30, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 30, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 30, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 30, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 17, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 17, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 1, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 31, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 5, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 5, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Aug 16, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 4, 2023 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Feb 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 7, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Feb 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 5, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 8, 2021 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 8, 2021 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Jun 8, 2021 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jun 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2021 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 19, 2021 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 19, 2021 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 13, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 13, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 13, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 12, 2021 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 12, 2021 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 12, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 12, 2021 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Apr 7, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 7, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 13, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 13, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 13, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 28, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 24, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 31, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jul 15, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 15, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 13, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2018 | NWAP | NEW APPLICATION ENTERED | — |